Inventor
VAN STUIVENBERG HERMAN H
NL17 patents
⚠️ This page may combine multiple inventors who share the name “VAN STUIVENBERG HERMAN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SOLVAY PHARM BV
11 patentsUS6974810B2Dec 13, 2005
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
SOLVAY PHARM BV31 citations91
US7319110B2Jan 15, 2008
1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
SOLVAY PHARM BV14 citations83
US7528162B2May 5, 2009
4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
SOLVAY PHARM BV20 citations82
US7608718B2Oct 27, 2009
4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
SOLVAY PHARM BV2 citations61
US7851630B2Dec 14, 2010
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
SOLVAY PHARM BV4 citations60
US7186741B2Mar 6, 2007
Neurotensin active 2,3,diaryl-pyrazolidine derivatives
SOLVAY PHARM BV6 citations58
US7495108B2Feb 24, 2009
Imidazoline derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations51
US7173044B2Feb 6, 2007
Imidazoline derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations51
US7498348B2Mar 3, 2009
1 H-imidazole derivatives as cannabinoid receptor modulators
SOLVAY PHARM BV0 citations50
US7271189B2Sep 18, 2007
1H-imidazole derivatives as cannabinoid receptor modulators
SOLVAY PHARM BV0 citations50
US7745476B2Jun 29, 2010
1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
SOLVAY PHARM BV0 citations41